Getting in Touch with Candida albicans: The Cell Wall of a Fungal Pathogen

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|4|505-512

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.4, 2006-04, pp. : 505-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 155-162

Bentham Science Publishers

Access to resources Recommend Favorite

Host-Pathogen Interactions and the Pathological Consequences of Acute Systemic Candida albicans Infections in Mice

By  

Current Drug Targets, Vol. 7, Iss. 4, 2006-04 ,pp. : 483-494

Bentham Science Publishers

Access to resources Recommend Favorite

Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2401-2419

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic cell wall targets in fungal infections

By Selitrennikoff C.P.   Ostroff G.R.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 53-72

Informa Healthcare

Access to resources Recommend Favorite

Fungal Cell Wall Inhibitors: Emphasis on Clinical Aspects

By  

Current Pharmaceutical Design, Vol. 6, Iss. 2, 2000-01 ,pp. : 225-239

Bentham Science Publishers

Access to resources Recommend Favorite